Shanghai Fudan-Zhangjiang FY26 H1 net profit attributable to shareholders more than doubles to RMB 36.89 million; revenue falls 4.58% to RMB 372.23 millionPUBT·11 hours ago01349-1.55%688505-1.80%
Fudan Zhangjiang Boosts Yield on Idle Cash With RMB210 Million SPD Bank DepositTip Ranks·Jul 2 at 04:40 AM688505-1.80%600000-0.77%
Fudan Zhangjiang Invests RMB150 Million in Low-Risk Bank of China Structured DepositTip Ranks·Jul 2 at 04:40 AM688505-1.80%BACHY+1.78%
Fudan-Zhangjiang Bio-Pharma Adopts Performance-Linked Pay Rules for Top ExecutivesTip Ranks·May 28 at 06:57 AM688505-1.80%01349-1.55%
2026 ASCO | Fudan-Zhangjiang anti-Trop2 antibody conjugate BB05 drug used for the treatment of non-small cell lung cancer Phase I clinical study results published同壁财经·May 21 at 10:21 PM01349-1.55%688505-1.80%
Fudan Zhangjiang Invests RMB210 Million in Low-Risk SPD Bank Structured DepositTip Ranks·Apr 7 at 06:18 AM688505-1.80%600000-0.77%
"Performance" Shanghai Fudan's annual net profit is 232 million RMB, a decrease of 59.4%, with a dividend of 0.58 RMB per 10 sharesAASTOCKS·Mar 29 at 07:13 AM688505-1.80%01349-1.55%
"Profit Warning" Fudan-Zhangjiang estimates a full-year loss of 120 million to 180 million RMBAASTOCKS·Feb 1 at 04:39 AM159316-1.40%159837-1.56%
Fudan-Zhangjiang Deploys RMB110 Million in Low-Risk Structured DepositsTip Ranks·Jan 7 at 03:39 AM01349-1.55%688505-1.80%
Fudan-Zhangjiang Places RMB150 Million in Low-Risk Bank of China Structured DepositTip Ranks·Jan 6 at 04:08 AM01349-1.55%688505-1.80%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd And 2 Other Asian Penny Stocks To Watch CloselySimplywall·Jan 5 at 10:35 PM00434+1.15%01349-1.55%
